BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1880588)

  • 1. Iodine-131 whole-body scan for post-surgical follow-up of differentiated thyroid carcinoma.
    Degrossi OJ; García del Río H; Degrossi EB
    J Nucl Med; 1991 Sep; 32(9):1826. PubMed ID: 1880588
    [No Abstract]   [Full Text] [Related]  

  • 2. [Postoperative follow-up in differentiated carcinoma of the thyroid gland].
    Pandolfi C
    Minerva Med; 1986 Jun; 77(27):1317-9. PubMed ID: 3725155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should high hTg levels in the absence of iodine uptake be treated?
    Britton KE; Foley RR; Chew SL
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):794-5. PubMed ID: 12616324
    [No Abstract]   [Full Text] [Related]  

  • 4. [Importance of scintigraphy in the evaluation of surgical treatment outcome in differentiated cancer of the thyroid gland].
    Protsyk VS; Shishkina VV; Chebotareva ED; Siniuta BF; Dzhuzha DA; Sagan DL
    Klin Khir; 1997; (9-10):29-32. PubMed ID: 9511322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should high hTg levels in the absence of iodine uptake be treated?
    Biermann M; Schober O
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):160-3. PubMed ID: 12583404
    [No Abstract]   [Full Text] [Related]  

  • 6. Should high hTg levels in the absence of iodine uptake be treated?
    Lind P
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):157-60. PubMed ID: 12583362
    [No Abstract]   [Full Text] [Related]  

  • 7. Outline for the treatment of differentiated thyroid carcinomas by total thyroidectomy and complementary radioiodine.
    Savoie JC; Massin JP
    Ann Radiol (Paris); 1977; 20(8):822-5. PubMed ID: 610556
    [No Abstract]   [Full Text] [Related]  

  • 8. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
    Ronga G; Fiorentino A; Paserio E; Signore A; Todino V; Tummarello MA; Filesi M; Baschieri I
    J Nucl Med; 1990 Nov; 31(11):1766-71. PubMed ID: 2121913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The case for obtaining a diagnostic whole-body scan prior to iodine 131 treatment of differentiated thyroid cancer.
    McDougall IR
    Thyroid; 2009 Aug; 19(8):811-3. PubMed ID: 19645613
    [No Abstract]   [Full Text] [Related]  

  • 10. [Utility and limits of nuclear medicine in the follow-up of differentiated thyroid carcinoma].
    Chiti A; Orunesu E; Rodari M
    Ann Ital Chir; 2006; 77(3):215-22. PubMed ID: 17137036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
    Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V
    Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases.
    Leung SF; Law MW; Ho SK
    Br J Radiol; 1992 Oct; 65(778):905-9. PubMed ID: 1422665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma.
    Reiners C; Biko J; Haenscheid H; Hebestreit H; Kirinjuk S; Baranowski O; Marlowe RJ; Demidchik E; Drozd V; Demidchik Y
    J Clin Endocrinol Metab; 2013 Jul; 98(7):3039-48. PubMed ID: 23616148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of the diagnostic total body scan in differentiated thyroid cancer.
    Doi SA
    J Clin Endocrinol Metab; 2001 Feb; 86(2):949-50. PubMed ID: 11158080
    [No Abstract]   [Full Text] [Related]  

  • 15. Moderate hypothyroidism in preparation for whole body 131I scintiscans and thyroglobulin testing.
    Greenspan FS
    Thyroid; 1996 Oct; 6(5):493. PubMed ID: 8936677
    [No Abstract]   [Full Text] [Related]  

  • 16. Radioiodine therapy of carcinoma of the thyroid.
    McConnell R
    J Surg Oncol; 1981; 16(3):251-4. PubMed ID: 7218808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 131I total body scan and serum thyroglobulin assay in the follow-up of surgically treated patients affected by differentiated thyroid carcinoma.
    Panza N; Lombardi G; Minozzi M; Salvatore M; Claudio F; Mariano A; Macchia V
    J Nucl Med Allied Sci; 1984; 28(1):9-12. PubMed ID: 6481470
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of serum thyroglobulin determination in the follow-up of differentiated carcinomas of the thyroid].
    Secades Ariz I; Pérez Piqueras JL; Labanda Tejedor P; Cordero Peinado J
    An Med Interna; 1988 Sep; 5(9):439-43. PubMed ID: 2856622
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
    Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
    J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages of surgical extirpation in addition to radioiodine therapy in differentiated thyroid carcinoma patients with a solitary large-volume skeletal metastasis with small-volume oligometastatic disease in the rest of the whole body.
    Basu S; Borde CR; Abhyankar A
    J Cancer Res Ther; 2012; 8(4):656-7. PubMed ID: 23361298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.